Dr. Geraldine Paulus is responsible for investment identification, due diligence, business development and new company creation activities at MPM.

Prior to joining MPM, Geraldine served as the Director of Research and Analytics at The Engine, leading technical and IP diligence, competitive landscape analysis and product/market research in support of the investment team as well as portfolio companies. She brings over a decade of academic experience, with a strong focus on translational and cross-disciplinary research in chemical engineering and biology.  During her Ph.D. studies in Dr. Michael Strano’s lab (MIT) she developed novel applications for nanomaterials, ranging from nanoelectronics to biosensors. As a postdoctoral researcher, she worked in the lab of Dr. Ramnik Xavier (MGH, The Broad Institute) implementing CRISPR technology to elucidate gene functions in (auto)immune disorders. Geraldine has interned at the Partners Innovation Fund and consulted for an early-stage Flagship Pioneering-backed company.

Geraldine holds B.S. and M.S. degrees in Chemical Engineering from the KU Leuven (Belgium) and a Ph.D. in Chemical Engineering from MIT.